P2-073: High insulin-like growth factor 1 receptor (IGF1R) expression is associated with poor survival in surgically treated patients with non-small cell lung cancer (NSCLC) [PDF]
, 2007 Rafał Dziadziuszko +9 more
openalex +1 more source
Molecular and immune biomarker testing in squamous-cell lung cancer: Effect of current and future therapies and technologies [PDF]
, 2018 Bradley, Jeffrey D, et al,
core +1 more source
Pediatric Discovery, EarlyView.ABSTRACT Asthma, chronic pulmonary obstructive disease (COPD), cystic fibrosis, and acute respiratory infections are severe respiratory conditions that significantly contribute to global morbidity and mortality. Airway mucus hypersecretion is an important common pathophysiological and clinical manifestation of these diseases and is closely associated ...
Yuanyuan Zhang +4 more
wiley +1 more source
Advances in targeting KRAS mutations: A promising approach for the treatment of non‑small cell lung cancer (Review). [PDF]
Oncol RepSharma U, Song J, Kandu H, Zhu Y, Dai Z.
europepmc +1 more source
PP01.18 Real-world evaluation of racial and socioeconomic disparities in patients with NSCLC treated with immunotherapy [PDF]
Zachary Rivers +7 more
openalex +1 more source
482TiP Global, Phase 3 study of first-line durvalumab (MEDI4736) + tremelimumab vs standard of care platinum-based chemotherapy in advanced/metastatic NSCLC: NEPTUNE [PDF]
, 2016 Tony Mok +12 more
openalex +1 more source
Precision Medical Sciences, EarlyView.The nanoparticle polymeric micellar paclitaxel plus nedaplatin regimen demonstrates superior efficacy and tolerable toxicities compared to the paclitaxel–nedaplatin combination as a first‐line treatment for advanced esophageal squamous cell carcinoma.
Yu‐Qing Cao +7 more
wiley +1 more source
Targeting Growth Hormone Receptor to Overcome Therapy Resistance in Non-Small Cell Lung Cancer. [PDF]
Int J Mol SciAhmad A +9 more
europepmc +1 more source